Royce & Associates LP Clear Point Neuro, Inc. Transaction History

Royce & Associates LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.03 - $7.86 $143,875 - $187,539	-23,860 Reduced 44.96%	29,205 $198,000
Q4 2023 Feb 12, 2024	BUY	$4.46 - $7.07 $236,669 - $375,169	53,065 New	53,065 $360,000
Q1 2022 May 05, 2022	SELL	$7.8 - $11.6 $138,060 - $205,320	-17,700 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$11.08 - $18.86 $6.61 Million - $11.3 Million	-596,807 Reduced 97.12%	17,700 $199,000
Q3 2021 Nov 10, 2021	BUY	$16.58 - $22.25 $8.68 Million - $11.7 Million	523,607 Added 576.03%	614,507 $10.9 Million
Q2 2021 Aug 06, 2021	BUY	$17.23 - $22.77 $616,834 - $815,166	35,800 Added 64.97%	90,900 $1.74 Million
Q1 2021 May 10, 2021	BUY	$15.19 - $29.0 $836,969 - $1.6 Million	55,100 New	55,100 $1.17 Million

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.